Hemophilia Treatment Market Set for Rapid Growth
According to a new market research study titled ‘Hemophilia Treatment Market - Global Analysis and Forecasts by Product, Disease, Treatment Type, Therapy, and End User, the global hemophilia treatment market is expected to reach US$ 44,089.71 Mn in 2027 from US$ 14,454.81 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2020-2027. The report highlights the trends prevalent in the global hemophilia treatment market and the factors driving the market along with those that act as deterrents to its growth.
Hemophilia treatment refers to surgical supplies that helps to control blood loss and consists of hemophilia treatment agents present in the form of pads, sponges, patches, powders, liquids or others. Factors such as increasing number of surgical procedures, increasing incidence of sports injuries and technological advancements in hemophilia treatment are expected to account for the growth of the market.
Get Sample Copy of Report PDF: https://www.theinsightpartners.com/sample/TIPRE00008241/
The hemophilia treatment market by product is segmented into plasma derived coagulation factor concentrates, recombinant coagulation factor concentrates, antifibrinolytic agents, desmopressin. In 2019, the plasma derived coagulation factor concentrates segment held a largest market share of the hemophilia treatment market. This segment is also expected to dominate the market in 2027. The large share of plasma derived coagulation factor concentrates based hemophilia treatment can be attributed to various advantages offered by these hemophilia treatment, deep market penetration and variety of products offered by multiple players to suit diverse medical application. On the other hand, the recombinant coagulation factor concentrates segment is anticipated to witness the highest growth rate during the forecast period. Certain factors such as effectiveness of the hemophilia treatment in lesser time and better efficient blood clotting are expected to drive the segment growth.
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00008241/
Some of the prominent players operating in hemophilia treatment market are, Bayer AG, Sanofi, F. Hoffmann-la Roche Ltd., Kedrion S.P.A., CSL Limited, Biotest AG, Pfizer Inc., Novo Nordisk A/S, Octapharma AG, Baxter International Inc. The market players are focused towards launching new products in order to sustain their position in the market. For instance, in April 2019, Roche launched its product Emicizumab under the brand name Hemlibra in India for preventive treatment of Haemophilia A, an inherited disorder in which a person’s blood does not clot properly.
Browse More Related Reports by the insight partners:
Cosmeceuticals Market
https://www.theinsightpartners.com/reports/cosmeceutical-market
Dental Laboratories Market
https://www.theinsightpartners.com/reports/dental-laboratories-market
Discussion System Market
https://www.theinsightpartners.com/reports/discussion-system-market
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
